According to Fierce Pharma, “Merck & Co. has dodged billions of dollars in U.S. taxes by offshoring profits on Keytruda, according to an ongoing investigation by Democrats on the Senate Finance Committee.” But what about Merck employees who recognize that this is wrong? What are they willing to do?
SUMMARY: Via Axios – The antiviral pill that showed promising results against severe COVID-19 was initially developed at Emory University with $35 million of taxpayer grants. And while it costs $17.74 to produce, according to a report issued last week by drug pricing experts at the Harvard School of Public Health and King’s College Hospital in London. Merck charges the U.S. government $712 for the same amount of medicine or 40 times the price.